Results
Aarti Pharmalabs FY26 PAT Declines 31.5% YoY
Aarti Pharmalabs reported standalone FY26 PAT of ₹1,762 Mn, a 31.5% YoY decline due to forex losses and higher finance costs.
The company outlined a significant capex plan including ₹400 Cr Atali proj
